Literature DB >> 2598994

Hypotensive and peripheral vascular effects in healthy volunteers of repeated oral administration of pinacidil.

J L Saumet1, F Dubois, P Girard, A Geloen, J P Boissel.   

Abstract

The hypotensive and peripheral vascular effects of two different oral formulations of pinacidil were investigated in twelve healthy male volunteers. Arterial blood pressure, heart rate and calf blood flow were measured on Days 1 and 7. The vasodilator activity of both formulations was confirmed by a significant increase in calf blood flow on both days, which was correlated with a significant decrease in diastolic blood pressure. There was no differences between the tablet and the pellet.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2598994     DOI: 10.1007/bf00558137

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  8 in total

1.  Vascular effects in dogs of pinacidil (P 1134), a novel vasoactive antihypertensive agent.

Authors:  U B Olsen; E Arrigoni-Martelli
Journal:  Eur J Pharmacol       Date:  1983-04-08       Impact factor: 4.432

2.  Hemodynamic characterization of pinacidil in rats. Comparison with hydralazine.

Authors:  M J Thoolen; J C Van Meel; B Wilffert; P B Timmermans; P A van Zwieten
Journal:  Pharmacology       Date:  1983       Impact factor: 2.547

3.  Acute haemodynamic effects of pinacidil in man.

Authors:  D P Nicholls; J G Murtagh; M E Scott; P Morton; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1986-09       Impact factor: 4.335

4.  Pharmacokinetics and hypotensive effect in healthy volunteers of pinacidil, a new potent vasodilator.

Authors:  J W Ward; A McBurney; P R Farrow; P Sharp
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

5.  N''-cyano-N-4-pyridyl-N'-1,2,2-trimethylpropylguanidine, monohydrate (P 1134): a new, potent vasodilator.

Authors:  E Arrigoni-Martelli; C K Nielsen; U B Olsen; H J Petersen
Journal:  Experientia       Date:  1980-04-15

6.  Pinacidil monotherapy for hypertension.

Authors:  J W Ward
Journal:  Br J Clin Pharmacol       Date:  1984-08       Impact factor: 4.335

7.  Pinacidil, a new vasodilator: pharmacokinetics and pharmacodynamics of a new retarded release tablet in essential hypertension.

Authors:  J E Carlsen; T Kardel; H A Jensen; M Tangø; J Trap-Jensen
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

8.  Acute hemodynamic effects of pinacidil and hydralazine in essential hypertension.

Authors:  J E Carlsen; T Kardel; J O Lund; A McNair; J Trap-Jensen
Journal:  Clin Pharmacol Ther       Date:  1985-03       Impact factor: 6.875

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.